GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
104 hedge funds and large institutions have $1.62B invested in GW Pharmaceuticals Plc American Depositary Shares in 2015 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 35 increasing their positions, 23 reducing their positions, and 15 closing their positions.
87% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 15
66% more capital invested
Capital invested by funds: $975M → $1.62B (+$645M)
52% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 23
13% more funds holding
Funds holding: 92 → 104 (+12)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
46% less call options, than puts
Call options by funds: $38.6M | Put options by funds: $71.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PP
Prudential plc
London, England,
United Kingdom
|
+$71.1M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$61.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$54.2M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$39.8M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$20.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCP
Lamond Capital Partners
San Francisco,
California
|
-$15.6M |
| 2 |
Jennison Associates
New York
|
-$9.12M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$3.9M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.9M |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$2.96M |
GWPH Hedge Fund Activity: Q2 2015 in Review
104 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2015, worth a combined $1.62B — up 66% from $975M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new GWPH positions and 15 closed out — a net gain of 13 holders — while 35 added to existing stakes and 23 trimmed.
The largest buyer was Prudential plc, adding an estimated $71.1M. The largest seller was Lamond Capital Partners, exiting entirely with an estimated $15.6M sold.
- 104 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2015, up from 92 in Q1 2015.
- Funds reported $1.62B of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2015, up 66% quarter-over-quarter.
- 28 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2015 and 15 closed out, a net change of +13 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q2 2015 was Prudential plc, an estimated $71.1M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2015 was Lamond Capital Partners, an estimated $15.6M sold.
Based on aggregated 13F filings for Q2 2015.